Arthur He Stock Analyst Profile - HC Wainwright & Co. Research Coverage - Stocknear

Arthur He

Stock Analyst at HC Wainwright & Co.

(4.9)
# 654
Out of 5,497 analysts
90
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

12 Stocks

Name Action PT Current % Upside Ratings Updated
ADAG Adagene
Maintains: Buy
8 7
2.04 243.14% 11 Aug 15, 2025
LVTX LAVA Therapeutics
Maintains: Neutral
2 2
1.53 -18.95% 11 Aug 5, 2025
AUPH Aurinia Pharmaceutic...
Assumes: Buy
17
11.27 50.84% 1 Jul 30, 2025
ADAP Adaptimmune Therapeu...
Downgrades: Neutral
n/a
n/a n/a 7 Jul 29, 2025
NKTR Nektar Therapeutics
Maintains: Strong Buy
7 120
58.07 106.65% 4 Jun 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
5.9 238.98% 10 Jun 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
75 85
29.54 187.75% 2 Jun 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 8 May 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 8 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 7 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 9
n/a n/a 17 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
39
n/a n/a 4 May 28, 2024